Kodiak Sciences Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| KOD | IDYA | SRZN | 9995.HK | KRYS | 688382.SS | |
|---|---|---|---|---|---|---|
| Market cap | 6.19B | 3.12B | 553.72M | 40.23B | 9.21B | 8.38B |
| P/E (TTM) | — | — | — | 6.1 | 42.2 | — |
| Forward P/E | -28.7 | -7.9 | -7.6 | 46.7 | 34.0 | -43.8 |
| Price/book | 101.1 | 2.9 | -1.7 | 3.8 | 6.4 | 6.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +454.63% | +5.63% | +142.51% | −19.94% | +52.61% | −48.70% |
| Today | −0.38% | +3.29% | +5.08% | +1.49% | +1.90% | +4.33% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All KOD news ›Zenkuda for wet AMD ‘impressive and encouraging’ at 1 year
Take Homes in AMD Zenkuda for wet AMD âimpressive and encouragingâ at 1 year NEW ORLEANS â In this video, David A. Eichenbaum, MD, FASRS, of Retina Vitreous Associates of Florida, highlights data from the phase 3 DAYBREAK trial on…
Kodiak AI (KDK) Gets a Buy from Citi
In a report released today, Michael Ward from Citi maintained a Buy rating on Kodiak AI, with a price target of $8.50. According to TipRanks, Ward is a 4-star analyst with an average return of 5.6% and a 53.72% success rate. Ward covers…
Analysts Have Conflicting Sentiments on These Healthcare Companies: Kodiak Sciences (KOD), Newron Pharmaceuticals SpA (OtherNWPHF) and Illumina (ILMN)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kodiak Sciences (KOD), Newron Pharmaceuticals SpA (NWPHF) and Illumina (ILMN). In a report released today, Matthew Caufield from H.C. Wainwright reiterated a…
Kodiak AI (NASDAQ:KDK) Price Target Cut to $4.50 by Analysts at Chardan Capital
Posted by Danessa Lincoln on Oct 22nd, 2026 Kodiak AI (NASDAQ:KDK – Get Free Report) had its price target decreased by investment analysts at Chardan Capital to $4.50 in a report released on Thursday, Benzinga reports. The brokerage…
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.7% – Here’s What Happened
Posted by Mitch Edgeman on Oct 21st, 2026 Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report)’s share price was down 5.7% during mid-day trading on Wednesday. The company traded as low as $87.32 and last traded at $87.6450. 666,433 shares…
KOD Stock Explodes As Zenkuda Trial Data Rewire Wall Street
Kodiak Sciences Inc stocks have been trading up by 7.91 percent after promising trial data boosted optimism for its eye drug Kodiak Sciences Inc (KOD) has gone from quiet biotech to momentum magnet. The DAYBREAK data in late September…
Kobrea hires Oak Hill for investor outreach
Kobrea Exploration (CSE:KBX) has hired Oak Hill Financial for investor relations and marketing services under a six-month agreement aimed at raising the Canadian explorer’s profile among investors. The six-month agreement took effect on 14…
KOD Stock Rockets As DAYBREAK Trial Rewrites Biotech Expectations
Kodiak Sciences Inc surged as pivotal clinical trial progress fueled investor optimism, and its stocks have been trading up by 8.56 percent. Kodiak Sciences, trading under ticker KOD, has gone from quiet biotech to front-page momentum…
Recent Investment Analysts’ Ratings Changes for Kodiak Sciences (KOD)
Posted by Danessa Lincoln on Oct 16th, 2026 A number of research firms have changed their ratings and price targets for Kodiak Sciences (NASDAQ: KOD): Kodiak Sciences Inc (NASDAQ: KOD) is a clinical-stage biopharmaceutical company focused…
Citigroup raises Krystal Biotech price target on Vyjuvek sales and promising KB113 trial results
Citigroup increased its price target for Krystal Biotech to $416 from $386, citing strong Q2 revenue of $119.2 million from its approved product Vyjuvek and encouraging early clinical data for KB113, a treatment for basal cell carcinomas…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com9
- themarketsdaily.com8
- markets.businessinsider.com2
- stocktitan.net2
- timothysykes.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 29 articles, not a forecast.